Detalles de la búsqueda
1.
The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy.
Nanomedicine
; 12(1): 109-22, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26472049
2.
Functional proteome of macrophage carried nanoformulated antiretroviral therapy demonstrates enhanced particle carrying capacity.
J Proteome Res
; 12(5): 2282-94, 2013 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-23544708
3.
Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1-infected human peripheral blood lymphocyte-reconstituted mice.
J Infect Dis
; 206(10): 1577-88, 2012 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22811299
4.
Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy.
PLoS One
; 10(12): e0145966, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26716700
5.
Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages.
J Control Release
; 150(2): 204-11, 2011 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-21108978
6.
Comparative manufacture and cell-based delivery of antiretroviral nanoformulations.
Int J Nanomedicine
; 6: 3393-404, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22267924
7.
Methods development for blood borne macrophage carriage of nanoformulated antiretroviral drugs.
J Vis Exp
; (46)2010 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-21178968
Resultados
1 -
7
de 7
1
Próxima >
>>